Virtus ETF Advisers LLC Axsome Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

  • $234 Million
  • Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 3,705 shares of AXSM stock, worth $485,910. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,705
Previous 4,542 18.43%
Holding current value
$485,910
Previous $408,000 23.28%
% of portfolio
0.13%
Previous 0.2%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$83.08 - $100.49 $69,537 - $84,110
-837 Reduced 18.43%
3,705 $313,000
Q2 2024

Aug 14, 2024
SELL
$65.72 - $80.5 $43,243 - $52,969
-658 Reduced 12.65%
4,542 $365,000
Q1 2024

May 15, 2024
BUY
$69.39 - $97.64 $51,903 - $73,034
748 Added 16.8%
5,200 $414,000
Q4 2023

Feb 15, 2024
BUY
$57.42 - $83.61 $39,619 - $57,690
690 Added 18.34%
4,452 $354,000
Q3 2023

Nov 07, 2023
SELL
$69.25 - $82.21 $33,586 - $39,871
-485 Reduced 11.42%
3,762 $262,000
Q2 2023

Aug 14, 2023
BUY
$58.41 - $90.35 $22,604 - $34,965
387 Added 10.03%
4,247 $305,000
Q1 2023

May 15, 2023
BUY
$58.39 - $75.0 $3,795 - $4,875
65 Added 1.71%
3,860 $238,000
Q4 2022

Feb 14, 2023
SELL
$39.94 - $79.72 $264,322 - $527,586
-6,618 Reduced 63.56%
3,795 $292,000
Q3 2022

Nov 14, 2022
BUY
$36.06 - $69.85 $5,553 - $10,756
154 Added 1.5%
10,413 $465,000
Q2 2022

Aug 12, 2022
BUY
$21.74 - $46.75 $113,178 - $243,380
5,206 Added 103.03%
10,259 $393,000
Q1 2022

May 16, 2022
SELL
$23.7 - $41.39 $7,038 - $12,292
-297 Reduced 5.55%
5,053 $209,000
Q4 2021

Feb 14, 2022
BUY
$30.7 - $43.36 $67,662 - $95,565
2,204 Added 70.06%
5,350 $202,000
Q3 2021

Nov 15, 2021
SELL
$19.91 - $68.26 $3,324 - $11,399
-167 Reduced 5.04%
3,146 $104,000
Q2 2021

Aug 10, 2021
SELL
$50.63 - $73.5 $22,530 - $32,707
-445 Reduced 11.84%
3,313 $223,000
Q1 2021

May 17, 2021
BUY
$55.91 - $81.44 $3,801 - $5,537
68 Added 1.84%
3,758 $213,000
Q4 2020

Feb 12, 2021
SELL
$66.31 - $86.52 $38,393 - $50,095
-579 Reduced 13.56%
3,690 $301,000
Q3 2020

Nov 13, 2020
SELL
$68.34 - $85.84 $38,953 - $48,928
-570 Reduced 11.78%
4,269 $304,000
Q2 2020

Aug 05, 2020
SELL
$49.87 - $98.69 $142,079 - $281,167
-2,849 Reduced 37.06%
4,839 $398,000
Q1 2020

May 14, 2020
SELL
$41.2 - $101.31 $45,855 - $112,758
-1,113 Reduced 12.65%
7,688 $452,000
Q4 2019

Feb 13, 2020
SELL
$16.71 - $106.24 $38,015 - $241,696
-2,275 Reduced 20.54%
8,801 $910,000
Q3 2019

Nov 12, 2019
SELL
$20.24 - $29.16 $12,467 - $17,962
-616 Reduced 5.27%
11,076 $224,000
Q2 2019

Aug 13, 2019
BUY
$13.46 - $25.75 $157,374 - $301,069
11,692 New
11,692 $301,000

Others Institutions Holding AXSM

# of Institutions
348
Shares Held
36.2M
Call Options Held
1.32M
Put Options Held
1M
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $5.62B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email